Current Issue January 2012, Vol. 95, No. 1
Editor-in-Chief

Stephen Colagiuri, MD
Stephen Colagiuri is Professor of Metabolic Health at the University of Sydney. His research interests focus on development and implementation of evidence-based guidelines, cardiometabolic risk assessment, diabetes screening and prevention, the glycemic index, and economic aspects of diabetes and obesity. He has over 100 publications in scientific journals and books. He is a past President of the Australian Diabetes Society. He is a member of the Diabetes Expert Advisory Committee of the Commonwealth Department of Health and Aged Care, chair of the International Diabetes Federation Global Guideline Working Group, and an advisor on diabetes to the World Health Organization.
Issue Highlights
Review
-
Metformin effects revisitedJanuary 2012(Vol. 95 | No. 1 | Pages 1-9)
Clinical care and education
-
Starting or switching to biphasic insulin aspart 30 (BIAsp 30) in type 2 diabetes: A multicenter, observational, primary care study conducted in FinlandJanuary 2012(Vol. 95 | No. 1 | Pages 10-18)
-
Which metabolic syndrome criteria best predict the presence of non-alcoholic fatty liver disease?January 2012(Vol. 95 | No. 1 | Pages 19-24)
-
The impact of structured blood glucose testing on attitudes toward self-management among poorly controlled, insulin-naïve patients with type 2 diabetes24 January 2012
-
Hypoglycemia is associated with increased worry and lower quality of life among patients with type 2 diabetes treated with oral antihyperglycemic agents in the Asia-Pacific region24 January 2012
-
Rural diabetes prevalence quintuples over twenty-five years in low- and middle-income countries: A systematic review and meta-analysis19 January 2012
-
Predictors of suboptimal glycaemic control in type 2 diabetes patients: The role of medication adherence and body mass index in the relationship between glycaemia and age19 January 2012
-
Combination therapy with liraglutide and sulfonylurea for a type 2 diabetic patient with high titer of anti-insulin antibodies produced by insulin therapy18 January 2012





